ArticleRisk management and healthcare policy2026
Impact of Laboratory Data Integration into Outpatient Prescriptions on Community Pharmacist Feedback and Physician Responses: A Single-Center Retrospective Study.
Article in Risk management and healthcare policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Laboratory data with outpatient prescriptions have expanded, and their usefulness has been reported. However, the effect of a modification in laboratory data provision on the content of tracing reports (TRs) submitted by community pharmacists to provide clinical feedback to physicians and on physician responses remains unclear. This study aimed to evaluate the impact of a system-level modification in laboratory data provision on the inclusion of laboratory data-related descriptions in TRs and to assess the association between TR characteristics and physician responses. Patients and Methods: We used TRs submitted by community pharmacies to a university hospital in Japan. An integrated prescription format (IPF), containing laboratory data automatically printed on prescriptions, was introduced in addition to the existing separate sheet format (SSF). Laboratory data-related descriptions in the TRs were compared pre- and post-implementation. Physician responses were evaluated, and associated factors were analyzed using logistic regression. Results: Laboratory data provision using SSF remained approximately 4% pre- and post-implementation, whereas IPF printed laboratory data fields on all prescriptions post-implementation. A total of 761 TRs were analyzed (pre-implementation, 389; post-implementation, 372). Laboratory data-related descriptions were identified in 16 TRs (2.1%), with a significant increase post-implementation (1.0% vs 3.2%; odds ratio [OR] 3.21, 95% confidence interval [CI] 1.03-10.04). Physician responses were recorded for 210 TRs (27.6%), with no significant difference pre- and post-implementation (27.8% vs 27.4%; OR 0.98, 95% CI 0.71-1.35). Multivariable analysis showed a strong association between pharmacists' proposals or concerns and physician responses (adjusted OR 10.39, 95% CI 5.39-20.03). Conclusion: The IPF-based laboratory data provision system increased inclusion of laboratory data-related descriptions in TRs but not physician responses. The findings suggest that providing information that includes clinically relevant proposals or concerns, rather than simply increasing the amount of information available, may be more important for promoting physician responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.